FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND enters OPUS GENETICS, INC. with 2.56M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/29/2024ACC: 0001578563-24-000432
→
DirectorOther
Since Oct 2024
2.56M
Baseline shares
100% direct
2.56M
Direct ownership
1 position
6.93K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.56M
Total
2.56M direct2.56M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.56M | Direct |
| Total | 2.56M | 2.56M direct |
Derivative Holdings1
Series A Non-Voting Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
6.93K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
6.93K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Non-Voting Convertible Preferred Stock Direct | Common Stock | — | — | 6.93K | N/A | |
| Total | 6.93K | 0.00 | ||||